Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression

被引:143
|
作者
Bruno, Antonino [1 ]
Mortara, Lorenzo [2 ]
Baci, Denisa [3 ]
Noonan, Douglas M. [1 ,2 ]
Albini, Adriana [1 ,3 ]
机构
[1] IRCCS MultiMed, Sci & Technol Pole, Milan, Italy
[2] Univ Insubria, Lab Immunol & Gen Pathol, Dept Biotechnol & Life Sci, Varese, Italy
[3] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
关键词
myeloid derived suppressor cell (MDSC); natural killer cells (NK cells); angiogenesis; cytokines; tumor microenvironment; decidua; NITRIC-OXIDE SYNTHASE; HUMAN NK CELLS; ENDOTHELIAL GROWTH-FACTOR; INNATE LYMPHOID-CELLS; ANTI-VEGF THERAPY; TGF-BETA; HEPATOCELLULAR-CARCINOMA; ANTITUMOR IMMUNITY; RETINOIC ACID; T-CELLS;
D O I
10.3389/fimmu.2019.00771
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) contribute to the induction of an immune suppressive/anergic, tumor permissive environment. MDSCs act as immunosuppression orchestrators also by interacting with several components of both innate and adaptive immunity. Natural killer (NK) cells are innate lymphoid cells functioning as primary effector of immunity, against tumors and virus-infected cells. Apart from the previously described anergy and hypo-functionality of NK cells in different tumors, NK cells in cancer patients show pro-angiogenic phenotype and functions, similar to decidual NK cells. We termed the pro-angiogenic NK cells in the tumor microenvironment "tumor infiltrating NK" (TINKs), and peripheral blood NK cells in cancer patients "tumor associated NK" (TANKs). The contribution of MDSCs in regulating NK cell functions in tumor-bearing host, still represent a poorly explored topic, and even less is known on NK cell regulation of MDSCs. Here, we review whether the crosstalk between MDSCs and NK cells can impact on tumor onset, angiogenesis and progression, focusing on key cellular and molecular interactions. We also propose that the similarity of the properties of tumor associated/tumor infiltrating NK and MDSC with those of decidual NK and decidual MDSCs during pregnancy could hint to a possible onco-fetal origin of these pro-angiogenic leukocytes.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] The Roles of Myeloid-Derived Suppressor Cells in Liver Disease
    Zhang, Chunye
    Sui, Yuxiang
    Liu, Shuai
    Yang, Ming
    BIOMEDICINES, 2024, 12 (02)
  • [42] Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes
    Wang, Shiqi
    Tan, Qian
    Hou, Yayi
    Dou, Huan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [43] BONE MARROW-DERIVED CELLS SERVE AS PRO-ANGIOGENIC MACROPHAGES BUT NOT ENDOTHELIAL CELLS IN WOUND HEALING
    Okuno, Y.
    Ishizu, A.
    Kishi, K.
    Suda, T.
    Kubota, Y.
    WOUND REPAIR AND REGENERATION, 2013, 21 (01) : A3 - A3
  • [44] Myeloid-Derived Suppressor Cells Confer Tumor-Suppressive Functions on Natural Killer Cells via Polyinosinic:Polycytidylic Acid Treatment in Mouse Tumor Models
    Shime, Hiroaki
    Kojima, Ayako
    Maruyama, Akira
    Saito, Yusuke
    Oshiurni, Hiroyuki
    Matsumoto, Misako
    Seya, Tsukasa
    JOURNAL OF INNATE IMMUNITY, 2014, 6 (03) : 293 - 305
  • [45] Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
    Shuiling Jin
    Zhenzhen Yang
    Xin Hao
    Wenxue Tang
    Wang Ma
    Hong Zong
    Biomarker Research, 8
  • [46] Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
    Jin, Shuiling
    Yang, Zhenzhen
    Hao, Xin
    Tang, Wenxue
    Ma, Wang
    Zong, Hong
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [47] Pro-Angiogenic Activity of Monocytic-Type Myeloid-Derived Suppressor Cells from Balb/C Mice Infected with Echinococcus Granulosus and the Regulatory Role of miRNAs
    Yin, Jian-hai
    Liu, Cong-shan
    Yu, Ai-ping
    Yao, Jia-qing
    Shen, Yu-juan
    Cao, Jian-ping
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (03) : 1207 - 1220
  • [48] Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
    Joshi, Shweta
    Sharabi, Andrew
    PHARMACOLOGY & THERAPEUTICS, 2022, 235
  • [49] A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells
    Nishishita, T
    Ouchi, K
    Zhang, XH
    Inoue, M
    Inazawa, T
    Yoshiura, K
    Kuwabara, K
    Nakaoka, T
    Watanabe, N
    Igura, K
    Takahashi, TA
    Yamashita, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (01) : 24 - 31
  • [50] Myeloid-Derived Suppressor Cells Hamper Natural Killer Cell Activity in Cancer: Role of Peptidases
    Jakos, Tanja
    Pislar, Anja
    Jewett, Anahid
    Kos, Janko
    CRITICAL REVIEWS IN IMMUNOLOGY, 2021, 41 (02) : 77 - 99